Southland Equity Partners LLC Novartis Ag Transaction History
Southland Equity Partners LLC
- $494 Billion
- Q3 2025
A detailed history of Southland Equity Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Southland Equity Partners LLC holds 3,416 shares of NVS stock, worth $446,710. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,416
Previous 3,380
1.07%
Holding current value
$446,710
Previous $409 Million
7.1%
% of portfolio
0.09%
Previous 0.09%
Shares
16 transactions
Others Institutions Holding NVS
# of Institutions
1,560Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.36 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.18 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$989 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$931 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $281B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...